Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Thyroid ; 18(4): 469-72, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18399770

ABSTRACT

BACKGROUND: Amiodarone has a high iodine content that can induce persistent iodine excess and may prevent radioiodine (RI) treatment. PATIENT: A 55-year-old obese man had taken amiodarone (200 mg/d) for 3 years and stopped 2 years earlier. He underwent total thyroidectomy for papillary cancer with extrathyroidal extension and a metastatic central lymph node, requiring RI treatment. But iodine overload, with no other documented iodinated drug intake, was found (urinary iodine excretion = 472 microg/24 h; normal < 150 microg/24 h), and persisted 3 months later. Plasma exchanges (PE) were prescribed. INTERVENTIONS AND RESULTS: Eight PE over 4 weeks were needed to eliminate 39,295 nmol of iodine. Urinary iodine excretion and serum iodine concentrations, before PE and after eight sessions were, respectively: 230 and 84 nmol/mmol of creatinine, and 811 and 71 nmol/L, enabling RI treatment (4 GBq (131)I). Post-therapy whole-body scan revealed cervical uptake (0.48% of the total administered dose) corresponding to usual thyroid remnants. Ablation efficacy was confirmed 6 and 24 months later by cervical ultrasonography combined with an undetectable serum thyroglobulin level after recombinant human thyrotropin stimulation. CONCLUSIONS: When spontaneous iodine elimination is too slow to allow RI treatment of high-risk thyroid carcinoma within a reasonable time after thyroidectomy, PE are reliable and effective to overcome iodine overload.


Subject(s)
Iodine Radioisotopes/therapeutic use , Plasma Exchange/methods , Thyroid Neoplasms/radiotherapy , Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Humans , Iodine/adverse effects , Iodine/blood , Iodine/urine , Iodine Radioisotopes/adverse effects , Lymphatic Metastasis , Male , Middle Aged , Obesity/complications , Radiopharmaceuticals/adverse effects , Radiopharmaceuticals/therapeutic use , Thyroidectomy , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL